×

Pyrrolotriazine compounds as tam inhibitors

  • US 9,981,975 B2
  • Filed: 03/27/2017
  • Issued: 05/29/2018
  • Est. Priority Date: 03/28/2016
  • Status: Active Grant
First Claim
Patent Images

1. A compound, which is N-(4-(4-Amino-7-(1-isobutyrylpiperidin-4-yl)pyrrolo[1,2-f][1,2,4]triazin-5-yl)phenyl)-1-isopropyl-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide, or a pharmaceutically acceptable salt thereof.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×